SCHEMBL16487277

SCHEMBL16487277

C#CCCCCCCCCCSCCC(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TSHR P16473 3/20 0.41
ALDH1A1 P00352 3/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPK1 P28482 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.32
BHMT Q93088 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16510911 0.91 EPHX2 (0.41) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL17868081 0.91 EPHX2 (0.41) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL16487372 0.91 EPHX2 (0.41) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL1246192 0.82 MAPT (0.57) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL22836423 0.82 MAPT (0.57) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL17981462 0.82 MAPT (0.57) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL15541706 0.82 MAPT (0.57) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL2467407 0.82 MAPT (0.57) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL1049466 0.82 MAPT (0.57) MAPTHSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL3260470 0.82 MAPT (0.57) MAPTHSD17B10CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160185735-A1 FATTY ACID ANALOGS AND THEIR USE UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-06-30 US disclosed
US-20160185735-A1 FATTY ACID ANALOGS AND THEIR USE UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-06-30 US disclosed
US-20160185735-A1 FATTY ACID ANALOGS AND THEIR USE UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-06-30 US disclosed
WO-2015023631-A2 FATTY ACID ANALOGS AND THEIR USE ANDERSON CAROLYN (US) 2015-02-19 WO disclosed
WO-2015023631-A2 FATTY ACID ANALOGS AND THEIR USE ANDERSON CAROLYN (US) 2015-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185735-A1 FATTY ACID ANALOGS AND THEIR USE FABP4, ELOVL1, CPT1A MAPT 4417/4885HSD17B10 73/4885CYP1A2 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.